PMDA drug package insert
ファダプス錠10mg
PMDA Prescription drug · ダイドーファーマ株式会社 · package insert Jan 16, 2025
Key facts
| Brand names | ファダプス錠10mg |
|---|---|
| Nonproprietary names | アミファンプリジンリン酸塩 |
| Companies | 製造販売元（輸入）／ダイドーファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | ランバート・イートン筋無力症候群治療剤 |
| Therapeutic category codes | 87129 |
| YJ codes | 1290002F1028 |
| Approval numbers | 30600AMX00255000 |
| Package insert edition | 第2版 |
| Package insert date | Jan 16, 2025 |
| PMDA document key | 431095_1290002F1028_1 |
| PMDA company code | 431095 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: